Published on Spencer Knight via LinkedIn Sana Biotechnology has announced successful first-in-human results using HIP-engineered islet...

Published on Repligen Poster, Bioprocessing Summit (July 2023) With biologics becoming more complex and global manufacturing capacity...

Published on Repligen White Paper (July 2022) Facing growing demand for veterinary vaccines, MSD Animal Health partnered with Repligen to...

Published on Repligen Application Note (Sept 2024) Lentiviral vector production is a major bottleneck in CAR-T manufacturing, but...

Published on Repligen Brochure (Nov 2024) Repligen’s XCell ATF System brings upstream process intensification to life by enabling...

Published on Temple University News (August 28, 2024) In a major preclinical breakthrough, researchers at Temple University and Excision...

Published on Lonza Overview (CT-SP019) Scaling cell therapy from benchtop to bedside requires technologies that are efficient, compliant,...

Published on Lonza Poster Presentation (CT-PO024) Non-viral electroporation continues to gain ground as a safer, scalable alternative to...

Published on Spencer Knight via LinkedIn A landmark case in gene-editing has just unfolded: baby KJ, only nine months old and suffering...

Published on New England Journal of Medicine (May 15, 2025) A nine-month-old patient with fatal CPS1 deficiency has become the first...